It’s really hard to know what to make of this data without a control arm. The patient selection becomes key to estimating the effect of on the outcomes, but the

It’s really hard to know what to make of this data without a control arm. The patient selection becomes key to estimating the effect of on the outcomes, but the patients were not all extremely sick to start, and the patient inclusion criteria is super unclear. https://emcrit.org/pulmcrit/pulmcrit-eleven-reasons-the-nejm-paper-on-remdesivir-reveals-nothing/ https://emcrit.org/pulmcrit/pulmcrit-eleven-reasons-the-nejm...